Raynal NJ - Search Results

1

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.

Lemaire M, Momparler LF, Raynal NJ, Bernstein ML, Momparler RL. Lemaire M, et al. Among authors: raynal nj. Cancer Chemother Pharmacol. 2009 Feb;63(3):411-6. doi: 10.1007/s00280-008-0750-6. Epub 2008 Apr 9. Cancer Chemother Pharmacol. 2009. PMID: 18398609

2

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer.

Lemaire M, Chabot GG, Raynal NJ, Momparler LF, Hurtubise A, Bernstein ML, Momparler RL. Lemaire M, et al. Among authors: raynal nj. BMC Cancer. 2008 May 2;8:128. doi: 10.1186/1471-2407-8-128. BMC Cancer. 2008. PMID: 18454857 Free PMC article.

3

Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia.

Raynal NJ, Charbonneau M, Momparler LF, Momparler RL. Raynal NJ, et al. Oncol Res. 2008;17(5):223-30. doi: 10.3727/096504008786111356. Oncol Res. 2008. PMID: 18980019

4

3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.

Raynal NJ, Momparler LF, Rivard GE, Momparler RL. Raynal NJ, et al. Leuk Res. 2011 Jan;35(1):110-8. doi: 10.1016/j.leukres.2010.04.014. Epub 2010 May 26. Leuk Res. 2011. PMID: 20510451

5

Antileukemic activity of genistein, a major isoflavone present in soy products.

Raynal NJ, Momparler L, Charbonneau M, Momparler RL. Raynal NJ, et al. J Nat Prod. 2008 Jan;71(1):3-7. doi: 10.1021/np070230s. Epub 2007 Dec 29. J Nat Prod. 2008. PMID: 18163589

6

Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.

Huot M, Caron M, Richer C, Djibo R, Najmanovich R, St-Onge P, Sinnett D, Raynal NJM. Huot M, et al. Among authors: raynal njm. Cancer Chemother Pharmacol. 2021 Nov;88(5):845-856. doi: 10.1007/s00280-021-04339-6. Epub 2021 Jul 31. Cancer Chemother Pharmacol. 2021. PMID: 34331108

7

Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.

Raynal NJ, Lee JT, Wang Y, Beaudry A, Madireddi P, Garriga J, Malouf GG, Dumont S, Dettman EJ, Gharibyan V, Ahmed S, Chung W, Childers WE, Abou-Gharbia M, Henry RA, Andrews AJ, Jelinek J, Cui Y, Baylin SB, Gill DL, Issa JP. Raynal NJ, et al. Cancer Res. 2016 Mar 15;76(6):1494-505. doi: 10.1158/0008-5472.CAN-14-2391. Epub 2015 Dec 30. Cancer Res. 2016. PMID: 26719529 Free PMC article.

8

DNA Methylation-Targeted Drugs.

Da Costa EM, McInnes G, Beaudry A, Raynal NJ. Da Costa EM, et al. Among authors: raynal nj. Cancer J. 2017 Sep/Oct;23(5):270-276. doi: 10.1097/PPO.0000000000000278. Cancer J. 2017. PMID: 28926427 Review.

9

Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.

Dominici C, Sgarioto N, Yu Z, Sesma-Sanz L, Masson JY, Richard S, Raynal NJ. Dominici C, et al. Among authors: raynal nj. Clin Epigenetics. 2021 Mar 10;13(1):54. doi: 10.1186/s13148-021-01037-1. Clin Epigenetics. 2021. PMID: 33691794 Free PMC article.

10

Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.

Raynal NJ, Da Costa EM, Lee JT, Gharibyan V, Ahmed S, Zhang H, Sato T, Malouf GG, Issa JJ. Raynal NJ, et al. Mol Cancer Ther. 2017 Feb;16(2):397-407. doi: 10.1158/1535-7163.MCT-16-0588. Epub 2016 Dec 15. Mol Cancer Ther. 2017. PMID: 27980103 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page